LexinFintech Holdings Ltd. Announces US$50 million Share Repurchase Program
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
Stay updated with breaking news from Flexin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
LX earnings call for the period ending December 31, 2021.
Ucello Therapeutics ("Ucello"), a biotechnology company developing universal CAR-T therapies, announced the successful completion of...
SAN DIEGO, Calif. and CHENGDU, China, Feb. 10, 2022 /PRNewswire/ -- Ucello Therapeutics Completes US$25 Million Series A Financing
/PRNewswire/ -- Ucello Therapeutics ("Ucello"), a biotechnology company developing universal CAR-T therapies, announced the successful completion of a US$25...